Managing your diabetes can help prevent associated vision loss

Although there is no cure, diabetic retinal disease treatment has improved over the past two decades

5:00 AM

Author | Ananya Sen

two photos of the back of an eye
Retinal damage caused by diabetic retinal disease. Getty Images

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease (DRD).

Concerningly, DRD is the leading cause of preventable blindness for those aged 20-74 years.

Multiple studies have shown that DRD screening remains challenging because patients often do not have any symptoms in the early stages and, therefore, misunderstand the importance of regular screenings.

In a recent publication in Diabetes Technology & Therapeutics, Thomas Gardner, M.D., M.S., professor of ophthalmology and visual sciences and a member of Caswell Diabetes Institute, discusses current screening recommendations and treatment options for DRD.

Diabetes can damage multiple parts of the body, including kidneys, nerves and eyes. DRD affects the blood vessels and nerve cells in the retina, resulting in hemorrhages, abnormal blood vessel growth and loss of critical nerve cells.

“People usually are not motivated to take action until their vision is threatened, by which time they might develop late-stage DRD,” Gardner said.

The American Diabetes Association therefore recommends that adults with type 2 diabetes have their first eye exam when they are diagnosed and those with type 1 diabetes have their first eye exam within five years of diagnosis.

“The guidelines for type 1 and type 2 diabetes are different because adults who have the latter can develop vision complications before they become aware of their condition,” Gardner said. 

“Importantly, adolescents and young adults are at a higher risk, largely because it is very difficult for them to control their diabetes.”

Diabetes requires constant monitoring of blood sugar and diet.

“Sometimes patients can take the same amount of medication, eat the same food and get the same amount of exercise only to find that their blood sugar levels fluctuate. This makes it hard to manage,” Gardner said.

The biggest challenge for patients is lowering their blood sugar levels without becoming hypoglycemic, which is characterized by shakiness, uneven heartbeat, sweating and dizziness.

Although improvements in insulin pumps and continuous glucose monitors have made it easier to control blood sugar levels, Gardner emphasizes treating the other aspects of diabetes.

“People with diabetes need to have regular health checkups to ensure that their blood pressure is normal and all their organs are functioning correctly. Establishing good control on every facet of diabetes is essential,” he said.

Although the effect of diabetes on the retina is not completely understood, researchers have found several drugs that are promising.

In particular, those that help control blood pressure and lipid levels, including SGLT inhibitors, GLP-1 receptor activators and fenofibrate, can help slow the progression of DRD. However, these are generally prescribed by physicians and not ophthalmologists. 

“Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high cholesterol, ongoing studies have shown they can reduce the risk of vision loss in patients with diabetes,” Gardner said.

As a part of Caswell Diabetes Institute's Mary Tyler Moore Vision Initiative, Gardner and his colleagues are hoping to develop screening techniques that can catch DRD in its early stages and therapies that preserve and restore vision in people with diabetes.

“The prognosis for vision in people with diabetes is better now than it's ever been in the past. There's every reason to be optimistic that vision loss can be avoided with regular screenings and treatment,” Gardner said.

Additional authors: Ryan F. Bloomquist, Ph.D., M.P.H., University of South Carolina and Doan Tam Bloomquist, M.D., Charlie Norwood Veterans Affairs Hospital.

Paper cited: “Current Treatment Options for Diabetic Retinal Disease,” Diabetes Technology & Therapeutics. DOI: 10.1089/dia.2024.0548

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

Eye Care & Vision Diabetes Diabetic Retinopathy Ophthalmology Diabetes Management Metabolism, Endocrinology & Diabetes
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Thomas Gardner

Thomas W Gardner, MD, MS

Professor

Related

woman on left smiling and house on right painted white with greenery
Health Lab

Preserving an artist’s vision after diabetic retinal disease

Kim Hartman is an artist with Type 1 diabetes. She started developing vision problems and doctors at Michigan Medicine helped her slow the vision loss and manage it.
Health Lab

Diabetic Retinopathy: Know the Signs, Symptoms and Treatments

People with type 1 and 2 diabetes are at risk of diabetic retinopathy. Learn about diabetic retinopathy symptoms and treatment.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Adam Jacobson, M.D., uses ophthalmology equipment to examine the eyes of a pediatric patient.
Philanthropy News

Innovative children’s vision research gets a boost from the Knights Templar Eye Foundation

A $2 million gift from the Knights Templar Eye Foundation, Inc., will support innovative pediatric vision research and care at the Kellogg Eye Center.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.